AMD3100 leads to improved diabetic wound healing

被引：0
|
作者：
Allen, Robert J., Jr. [1 ]
Lin, Clarence D. [1 ]
Nyguen, Phoung D. [1 ]
Garfein, Evan [1 ]
Warren, Stephen M. [1 ]
机构：
[1] NYU, Sch Med, Inst Reconstruct Plast Surg, New York, NY USA
来源：
WOUND REPAIR AND REGENERATION | 2008年 / 16卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
177
引用
收藏
页码：A56 / A56
页数：1
相关论文
共 50 条
  • [1] The effects of AMD3100 on diabetic wound healing
    Allen, Robert J., Jr.
    Lin, Clarence D.
    Nguyen, Phuong D.
    Garfein, Evan
    Warren, Stephen M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 207 (03) : S59 - S59
  • [2] CXCR4 Antagonist AMD3100 Accelerates Impaired Wound Healing in Diabetic Mice
    Nishimura, Yukihide
    Ii, Masaaki
    Qin, Gangjian
    Hamada, Hiromichi
    Asai, Jun
    Takenaka, Hideya
    Sekiguchi, Haruki
    Renault, Marie-Ange
    Jujo, Kentaro
    Katoh, Norito
    Kishimoto, Saburo
    Ito, Aiko
    Kamide, Christine
    Kenny, John
    Millay, Meredith
    Misener, Sol
    Thorne, Tina
    Losordo, Douglas W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (03) : 711 - 720
  • [3] Improved bony healing with AMD3100 via neovascularization and osteogenesis
    Paek, Gina K.
    Wang, XiaoXia
    Allen, Robert J., Jr.
    Nguyen, Phuong D.
    Davidson, Edward H.
    Tutela, John P.
    Sailon, Alexander
    Saadeh, Pierre B.
    Warren, Stephen M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S62 - S63
  • [4] CXCR4-selective antagonist AMD3100 accelerates impaired wound healing in diabetic mice
    Nishimura, Y.
    Ii, M.
    Asai, J.
    Takenaka, H.
    Katoh, N.
    Hamada, H.
    Qin, G.
    Losordo, D. W.
    Kishimoto, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S4 - S4
  • [5] Plerixafor: AMD 3100, AMD3100, JM 3100, SDZ SID 791
    不详
    Drugs in R & D, 2007, 8 (2) : 113 - 119
  • [6] The bicyclam AMD3100 story
    Erik De Clercq
    Nature Reviews Drug Discovery, 2003, 2 : 581 - 587
  • [7] Potent stem cell mobilization by AMD3100 infusion, and functional analysis of AMD3100 mobilized cells
    Bonig, H.
    Papayannopoulou, T.
    VOX SANGUINIS, 2008, 95 : 27 - 27
  • [8] AMD3100/CXCR4 inhibitor
    De Clercq, Erik
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [9] Pharmacokinetics of AMD3100 in volunteers with renal impairment
    McFarland, R.
    Scarborough, R.
    Becker, S.
    Khong, A.
    Badel, K.
    Calandra, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S155 - S155
  • [10] Pharmacokinetics of AMD3100 in patients with haematologic malignancies
    McFarland, R.
    Stewart, D.
    Cashen, A.
    DiPersio, J.
    Badel, K.
    Calandra, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S132 - S132
12345